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INTRODUCTION  
INTRODUCTION 
Stress Urinary incontinence (SUI) is defined as involuntary 
leakage of urine on effort or exertion, or sneezing or coughing in the 
absence of bladder contraction. Stress urinary incontinence is extremely 
bothersome and can lead to significant interference in the quality of life 
in the female population. Stress urinary incontinence affects up to 40 % 
of women in the western world and 25% of women in India1. Women 
have a 4% risk of needing stress incontinence surgery during their 
lifetime, with nearly one third of surgeries performed due to recurrence. 
The tension free vaginal tape procedure described by Ulmsten has 
revolutionized the treatment of female stress urinary incontinence. This 
procedure had high cure rate when compared to Burch colposuspension. 
While these tapes have proved their long term efficacy, their insertion 
via an ascending or descending retropubic approach has been associated 
with number of intraoperative complications. 
The transobturator approach was first described by DeLorme in 
2001 for placement of midurethral vaginal tape with the objective of 
avoiding retropubic area. It consists of insertion of the tape through a 
skin incision in the thigh into the obturator foramen towards the urethra. 
Cadaveric dissections by various authors have proved this procedure is 
safer but complications like lower urinary tract injuries, vaginal tears 
and groin haematoma have been noted2. 
In 2003, a modified transobturator (inside out) approach was 
described to improve the intraoperative safety profile of the obturator 
approach.  In this inside out transobturator method, the needle serially 
passes through the infra-urethra area, the obturator foramen, and the 
inguinal area. Various studies involving cadaveric dissections has shown 
the transobturator tape was very much away from the pudendal nerve, 
obturator vessels and nerve, and the femoral vesslels. The risk of lower 
urinary tract injury or other visceral injury is negligible with this 
approach when compared to tension free vaginal tape or outside in 
transobturator approach. 
   
 
 
 
 
 
 
 
 
  
 
 
aims &  
objectives 
AIMS AND OBJECTIVES 
1) To evaluate the efficacy of inside out transobturator tape in the 
treatment of female stress urinary incontinence. 
2) To determine the influence of inside out transobturator tape on 
objective and subjective cure rate and quality of life in patients 
with stress urinary incontinence. 
3) To assess the postoperative complications and thus the safety of 
this procedure. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
REVIEW OF 
LITERATURE 
REVIEW OF LITERATURE 
Epidemiology of stress urinary incontinence  
Stress urinary incontinence (SUI) is extremely bothersome and 
can lead to significant interference in the quality of life in the female 
population. It is defined clinically as “involuntary loss of urine on effort 
or exertion, or sneezing or coughing”3. This sign may be reproduced by 
the clinician on examination. In addition to this, urodynamic 
observations may be undertaken to provide more precise although more 
invasive evaluations of incontinence. This is typically not required as 
women may be characterised as suffering from stress urinary 
incontinence by symptoms and signs alone and conservative measures 
undertaken to help treat the condition. However, if there is disparity in 
symptoms or surgical intervention is contemplated urodynamics is 
currently considered beneficial.  
The urodynamic definition of incontinence proposed by the 
International Continence Society is “the involuntary leakage of urine 
during increased intrabdominal pressure, in the absence of a detrusor 
contraction”. This is referred to as urodynamic stress urinary 
incontinence. It is in contradistinction to urge urinary incontinence, 
whereby a sudden desire to void occurs which cannot be deferred. This 
often shows detrusor overactivity during urodynamic testing. 
Occasionally both types of incontinence can occur simultaneously4.  
The definitions above were only coined by International 
Continence Society (ICS) in the year 2002. Prior to this the definitions 
of stress urinary incontinence were varied and thus reports of the 
prevalence of stress incontinence are variable. Hampel et al has reported 
the overall prevalence of urinary incontinence to be 16% in patients 
younger than 30 years and 29% in women between 30 to 60 years. It is 
more common in young and middle-aged women, who are more likely 
to work and to be sexually active whereas mixed urinary incontinence is 
predominant in older women5. Among all women the incidence of stress 
urinary incontinence, mixed incontinence and pure urge incontinence 
are 49%, 29% and 21% respectively6.  Moreover, it is believed that 
more than half of women suffering from stress urinary incontinence are 
embarrassed by the condition, are unable to mention it to their 
healthcare provider or may even accept some incontinence as part of the 
ageing process.  
Incontinence may be characterised by the impact caused by the 
symptoms on quality of life, by questionnaires like the Incontinence 
Impact Questionnaire7. As a measure of severity, the most widely used 
indexes are the Sandvik Severity Index, the ICIQ-UI SF index and 
Incontinence Quality of Life (I-QOL). These have been validated8. 
Anatomy of the pelvic floor 
 Female pelvic anatomy is a complex combination of 
muscles, ligaments, nerves, and blood vessels that act dynamically to 
provide support for the urethra, bladder, uterus, and rectum. An 
understanding of normal mechanisms of pelvic support is essential in the 
evaluation of women with stress urinary incontinence. 
Bone 
Passive support of the pelvic floor is provided by the bony 
structures, which act as anchors for the important muscular and fascial 
structures comprising the pelvic floor. The pubic rami, ischial spines, 
and sacrum represent the anchoring points of the true bony pelvis, which 
is made up of pubis, ilium, ischium, sacrum, and coccyx. The pelvic 
floor is diamond-shaped with the pubic symphysis and sacrum at the 
anterior and posterior apices while the ischial spines serve as lateral 
anchors9.  
 
Connective tissue 
The fascia overlying the pelvic floor musculature plays a critical 
role in pelvic support. The abdominal portion of the fascia is referred to 
as endopelvic fascia and represents a continuation of the abdominal 
transversalis fascia. The levator ani muscle is covered superiorly and 
inferiorly by a fascial layer. The two fascial layers split at the levator 
hiatus to cover the pelvic organs that traverse it. 
The pubourethral ligaments are a condensation of levator fascia 
connecting the inner surface of the inferior pubis to the midportion of 
the urethra and prevent its descent. This ligament along with the 
pubourethralis muscle supports the urethra and forms the midurethral 
complex10. 
 The urethropelvic ligaments are composed of a two-layer 
condensation of levator fascia, which provides the most important 
anatomic support of the bladder neck and proximal urethra to the lateral 
pelvic wall. The lateral fusions of the levator and periurethral fascia 
provide important, elastic musculofascial support to the bladder outlet, 
thereby maintaining passive continence in women. Voluntary or reflex 
contractions of the levator or obturator musculature increase the tensile 
forces across these ligaments, increasing outlet resistance and 
continence8. 
The pubocervical fascia is a continuous sheet of connective tissue 
support from pubic symphysis to cervix, including the periurethral, 
perivesical, and endopelvic fascia, which fuse to support the bladder to 
the lateral pelvic wall. It is continuous distally with the periurethral 
fascia and proximally with the uterine cervix and cardinal ligament 
complex.   
Musculature 
The striated musculature comprising the pelvic floor acts as a 
supporting structure for the visceral contents of the abdominopelvic 
cavity as well as a dynamic organ involved in maintenance of urinary 
and fecal continence. The pelvic diaphragm is composed of the levator 
ani and coccygeus muscles. The levator ani muscle group and its fascia 
provide the most critical support for the pelvic viscera, acting as the true 
muscular pelvic floor.  
The levator ani group is composed of the pubococcygeus, 
ischiococcygeus, and iliococcygeus, named according to their origin 
from the pelvic sidewall. This broad sheet of muscular tissue extends 
from the undersurface of the pubic symphysis to the pelvic surface of 
the ischial spines, taking origin from the tendinous arc laterally9.  
Midline apertures in the levator ani group, collectively referred to 
as the levator hiatus, allow passage of the urethra, vagina, and rectum. 
Adjacent fascial attachments provide support to these pelvic viscera as 
they exit the pelvis, fashioning a “hammock” of horizontal support. The 
bladder, proximal vagina, and rectum rest on the levator floor and 
become coapted against it during periods of increased intra-abdominal 
pressure. Resting tone of the levator muscle, as well as reflex and 
voluntary contraction, acts to pull the vagina and rectum forward, 
thereby preventing incontinence of both urine and stool. These active 
mechanisms of pelvic floor support maintain both urinary and fecal 
continence. 
Mechanisms of Urethral Continence in Women 
 Bladder outlet resistance in women is attained by several factors 
working together to provide continence at rest and during stress 
manoeuvres. Urethral anatomy, including functional length and elastic 
closure, is an important determinant of continence. In addition, activity 
of the muscular pelvic floor with its associated connective-tissue 
elements helps to maintain outlet resistance when there is increase in 
intraabdominal pressure10. The anatomic position of the urethra is 
another factor contributing to continence.  
Urethral Length 
The distance between internal meatus and external urethral 
meatus in a female determines anatomic length. Congenital anomalies 
and traumatic injuries may result in significant urethral loss with 
subsequent incontinence. Functional urethral length is determined by 
urethral pressure profilometry where the total urethral length is assessed 
by urethral pressure exceeding bladder pressures. The clinical utility of 
urethral length has not been consistently proven. Funnelling of the 
bladder neck and proximal urethra during straining cystography is seen 
in up to 50% of continent women 13.  
Furthermore, surgical incision of the bladder neck and Y-V plasty 
do not cause incontinence in women with otherwise normal outlets. In 
addition, resection of the distal one-third of the urethra does not produce 
incontinence. However, despite these observations, a critical length of 
healthy urethra is necessary to provide the coaptation for passive 
continence and continence during increases in abdominal pressure. 
Bladder neck suspensions may restore functional urethral length, 
thereby improving continence. 
Urethral Closure 
The urethra is made up of three functional anatomic components 
that result in an elastic, dynamic conduit with mucosal coaptation. The 
urethral mucosa is a transitional epithelium with numerous infoldings 
that allow distensibility and closure with excellent coaptation. Beneath 
the mucosa is a spongy tissue made up of vascular networks analogous 
to the corpus spongiosum in the male. Surrounding the spongy tissue is 
a thin musculofascial envelope, the periurethral fascia, which appears as 
a glistening white membrane. These three components create a coaptive 
seal11.  
Urethral closure is also affected by surrounding connective tissue 
structures. The pubourethral ligaments provide stability to the 
midurethra, especially during increases in intraabdominal pressure. In 
addition, the tensile strength of urethropelvic ligament along with the 
adjacent levator muscle facilitates compression of the proximal and 
midurethra. Finally, the striated musculature of the midurethral complex 
adds resting tone to the urethra, further effecting closure.  
Surrounding the sphincteric unit is skeletal musculature that 
provides an important additional mechanism for urethral closure. The 
striated musculature provides resting urethral tone as well as an 
involuntary reflex contraction in response to stress that increases 
coaptation. Furthermore, voluntary contraction also helps to prevent loss 
of urine by improving urethral closure12. These mechanisms increase 
urethral resistance, as measured by leak point pressures, but may not 
directly affect urethral pressures 
Pelvic Floor Activity during Increased Intra-Abdominal Pressure 
 Female continence is maintained during increases in 
intraabdominal pressure by several distinct mechanisms. Abdominal 
pressure is passively transmitted to the proximal urethra followed by an 
active contraction of the striated external sphincter musculature. 
Furthermore, the suburethral supportive layer, made up of periurethral 
fascia, anterior vaginal wall, and levator ani muscles, provides a firm 
backboard against which the urethra is compressed rapidly during 
increases in intra-abdominal pressure. Both the levator musculature and 
the urogenital diaphragm undergo reflex contraction, resulting in 
increased midurethral pressure. Furthermore, voluntary contraction of 
the levator and obturator muscles increases tension on the urethropelvic 
ligaments. These factors act in concert to promote urethral continence 
during changes in position and abdominal pressure. 
 
Anatomic Position 
 Both the bladder neck and the urethra are normally maintained in 
a high retropubic position relative to the more dependent bladder base, 
creating a valvular effect. They are supported by a musculofascial layer 
that suspends these structures from the pubic bone and pelvic sidewalls, 
thereby preventing their descent during increases in intra-abdominal 
pressures. A limited degree of bladder base rotation against a well-
supported urethra occurs with increased abdominal pressures, further 
creating a valvular effect between these two structures. Furthermore, 
direct transmission of intra-abdominal forces to a well-supported 
proximal urethra increases its resistance and promotes coaptation12. This 
complex set of compensatory mechanisms in a normal healthy woman 
allows maintenance of sufficient outlet resistance to promote 
continence, especially during episodes of abdominal stress such as 
coughing, sneezing, walking, and straining. 
  Any process that results in deterioration of these mechanisms can 
result in incontinence. Urethral function can be compromised by atrophy 
of its spongy tissue secondary to menopausal hormonal deficiency, 
altered neuromuscular function, or intrinsic damage from surgery, 
radiation, or trauma. In addition, a weakening of the levator musculature 
impairs the compensatory increases in midurethral pressures during 
stress. Although these physiologic changes can adversely impact on 
continence, the most common etiology of impaired outlet resistance in 
women is the loss of anatomic support of the bladder neck and urethra.  
 Relaxation of the pelvic floor as well as weakening of the 
urethropelvic ligaments and midurethral complex produces significant 
posterior and downward rotation of the urethra as well as bladder neck. 
The anatomic repositioning of these structures to a more dependent 
pelvic position eliminates the valvular effect. Sudden increases in intra-
abdominal forces facilitate funneling and opening of a poorly supported 
bladder outlet. The extra-abdominal location of the poorly supported 
proximal urethra and the loss of the backboard of strong normal support 
of the urethropelvic ligaments do not allow effective transmission of 
abdominal forces. Although such anatomic changes can lead to 
incontinence, urethral hypermobility does not always correlate with 
incontinence.  
 Many asymptomatic women with urethral hypermobility on 
physical examination do not report urinary incontinence. Thus, the 
anatomic position of the urethra alone does not correlate with the degree 
of incontinence. A component of intrinsic sphincter deficiency must be 
present along with these anatomic changes to create incontinence11. The 
factors responsible for pelvic floor relaxation rarely affect isolated 
anatomic areas. Thus, stress urinary incontinence resulting from urethral 
and bladder neck hypermobility is often accompanied by associated 
defects of pelvic support. 
  The identification of these concomitant defects is crucial to 
planning effective therapy, with restoration of pelvic support, anatomic 
vaginal axis, and outlet resistance. Defects in pelvic support can be 
organized according to their effects on various pelvic organs and 
structures, in order to allow a more systematic approach to treatment 
planning. The vaginal compartment contains a confluence of urinary, 
genital, and bowel organs. The goal of pelvic reconstructive surgery is 
to restore both anatomy and function. However, the restoration of 
anatomy does not always correlate with restoration of function.  
Risk factors 
Age: Increasing age was accepted as one of the risk factors for urinary 
incontinence. Stress urinary incontinence increases up to the age of 50, 
thereafter it is followed by little increase in the levels of prevalence. The 
mechanism in these cases may be the effect of the loss of muscle tone, 
long term effects of denervation injuries sustained during childbirth or 
changes in hormonal status leading to alterations in collagen in 
paravaginal tissues. However, it has proved difficult to show a link 
between natural menopause and increasing risk of stress urinary 
incontinence. Also the evidence for hormone replacement therapy does 
not show it to reduce the risk of the development of stress urinary 
incontinence as evidenced by two randomized control trials14. 
Heredity: Prevalence of stress urinary incontinence was almost three 
times higher (20.3% vs. 7.8%) in first-degree female relatives of women 
with stress urinary incontinence themselves14. These data suggest that 
there may be familial transmission of traits that can lead to an increased 
incidence of stress urinary incontinence. 
Obesity: Obesity has been cited as a risk factor for stress urinary 
incontinence, with women who have a higher body mass index 
displaying higher rates of stress incontinence. Women in the highest 
quartile of body mass index are two to four times more likely to have 
urinary incontinence than those in the lowest quartile14. This is 
postulated to be consequent upon the existence of a greater abdominal 
pressure and/ or laxity in support tissues caused by chronic strain.   
Hysterectomy: Data on the risk, hysterectomy confers on the 
development of subsequent urinary incontinence are conflicting. In one 
large, systematic review of the literature published from 1966 to 1997, 
Brown and colleagues constructed a summary estimate of the increased 
odds for development of urinary incontinence in women who undergo 
hysterectomy15. They found that among women 60 years of age, those 
who had a history of hysterectomy had an odds ratio of 1.6 compared to 
those without such a history. There was not a similar increase in odds 
for women younger than 60. They concluded that urinary incontinence 
following hysterectomy might not be seen until many years after the 
procedure. 
Pregnancy and Parity: Several studies suggest that parity is associated 
with increased risk of stress urinary incontinence. Investigators have 
documented incidence rates for urinary incontinence occurring after 
pregnancy as high as 26% at 6 months, although most women recover 
continence with time. Possible explanations for this relationship lie in 
pelvic floor denervation due to compression during pregnancy and 
delivery and stretching or tearing of pelvic floor connective tissue and 
musculature during pregnancy and delivery16. 
 In a prospective study 305 primiparas by Vikrup et al, has 
concluded that 32% had stress urinary incontinence during pregnancy. 
On followup, 19% of the continent women postpartum had stress 
urinary incontinence 5 years later, whereas female with stress urinary 
incontinence postpartum had an incidence of 92%. In another 
prospective study 344 nulliparous pregnant women were grouped into 
vaginal delivery and caesarean delivery groups. It was found that 
vaginal delivery group had stress urinary incontinence 18 times more 
than that of caesarean delivery group. Epidemiological studies have 
shown approximately half of all women develop transient urinary 
incontinence during pregnancy and post partum the prevalence of 
urinary incontinence is still 9-31%18. 
Smoking: Some evidence links stress urinary incontinence and urge 
incontinence with cigarette smoking in women. In a case control study, 
Bump and McClish examined 606 women with known smoking history 
(current, former, or never) and recorded the results of urodynamic tests 
for the 322 women who were incontinent. Urinary incontinence was 
significantly more prevalent in current and former smokers than in 
nonsmokers19.  
Medical Co-morbidities: Medical co-morbidities, such as, the length of 
time with type II diabetes mellitus have been found to confer increased 
risk of stress urinary incontinence20. Other co-morbidities presenting 
risk include neurological disorders and connective tissue disorders. 
GRADING OF STRESS URINARY INCONTINENCE 
Grade I: Incontinence occurs only with severe stress, such as coughing, 
sneezing, etc.  
Grade II: Incontinence with moderate stress, such as rapid movement or 
walking up and down stairs.  
Grade III: Incontinence with mild stress, such as standing. The patient is 
continent in the supine position. 
Evaluation of stress urinary incontinence 
The history, physical examination, and simple office testing may 
establish a preliminary diagnosis on which a clinician may begin 
treatment or may serve as an excellent screening tool to determine 
which individuals require further evaluation. If a complex or recurrent 
problem is present, surgery is planned, or the patient’s symptoms do not 
improve with initial treatment, specialized tests such as complex 
urodynamics should be employed to definitively establish diagnosis. 
Urogenital, gastrointestinal, musculoskeletal, neurologic, and 
endocrinologic factors may affect pelvic floor disorders, and a 
comprehensive history and physical examination begins the process of 
evaluating these conditions21. 
Bladder Diary 
Bladder diaries assist in providing quantitative data on urinary 
frequency, voiding intervals, the volume of continent voids, and the 
number of incontinent episodes. They also enable the clinician to better 
understand triggers of incontinence such as coughing, exercises, 
valsalva, or strenuous activity. The diary may help to establish voiding 
patterns that can help clinicians select appropriate behavioural 
interventions, and may also serve as a baseline of symptom severity for 
assessment of treatment efficacy.  
The cotton tip applicator test (Q-Tip) 
A sterile applicator with a small piece of cotton at its tip is 
introduced to reach the bladder neck. The angle between the applicator 
and the horizontal is measured. The patient then strains maximally using 
the valsalva manoeuvre. The rotational movement of the bladder neck 
around the symphysis pubis causes the Q-tip to move in a cranial 
direction. The angle of the Q-tip is measured relative to the horizontal 
using an orthopedic goniometer. A change of greater than 30 degrees is 
thought to represent a hypermobile urethra. This test does not establish 
the diagnosis of stress incontinence and does not add any extra 
information to the history and examination. However, it is thought by 
some clinicians to indicate the most appropriate continence procedure 
when urodynamic stress incontinence has been diagnosed and may 
predict failure after incontinence surgery22. 
 Stress test 
This test is performed in a moderately full bladder. The patient in 
the lithotomy position, the two labia is separated, and the patient is 
asked to cough. If there is leakage of urine, and stress urinary 
incontinence is demonstrated. 
Boney (Marshall) test 
It is indicated in case of a positive stress test associated with a 
cystocele, to know if incontinence is due to descent of bladder neck or 
weakness of the sphincter. The index and middle fingers are placed on 
both sides of the urethra to elevate the bladder neck upwards.  If no 
urine escapes on stress it means that the incontinence is due to descent 
of the bladder neck, but if urine still escapes it means weakness of the 
sphincter. 
Yousef test 
This test is indicated in case of a negative stress test associated 
with a large cystocele to diagnose hidden stress incontinence. The 
cystocele is reduced, the cervix is grasped with a volsellum and pushed 
upward, then the patient is asked to cough. If urine escapes, it indicates 
that the patient was continent because of kinking of the urethra. 
Urodynamics 
The need for pre-operative urodynamics is often justified by the 
consideration that pre-existing detrusor overactivity (DO) may either be 
a contra-indication for surgery or at least carries a worse prognosis. 
Therefore urodynamics is performed to detect factors that may 
unfavourably influence the outcome of the operation or confirm the 
diagnosis. The indications for urodynamic evaluation in patients with 
stress urinary incontinence are 1)to define incontinence when history in 
unclear 2)when planned for invasive or surgical treatment 3)failed 
conservative therapy 4)patients with mixed incontinence 5)failed anti-
incontinence surgery.  
Videourodynamic evaluation in women with stress incontinence 
provides information on the position and behaviour of the pelvic floor 
and urethra during stress and voiding22.  Cystocoeles are also easily 
diagnosed on video studies. It may be possible to demonstrate a change 
in symptomatic and urodynamic status after repositioning of the 
prolapsed organ. Abdominal leak point pressure and maximum urethral 
closure pressure are helpful in categorizing the patients with stress 
urinary incontinence into anatomical and instrinsic sphincter deficiency 
types of incontinence. 
Treatment of stress urinary incontinence 
Non surgical treatments  
The National Institute of Clinical Excellence (NICE)24 
recommends lifestyle changes such as weight loss and supervised pelvic 
floor exercises as first line therapy for the treatment of stress urinary 
incontinence. Failing this, electrical stimulation and biofeedback may be 
used. However, in one study, electrical stimulation has not shown to be 
effective compared to sham treatments in patients with the ability to 
contract pelvic floor musculature. Conversely, Castro et al. reported 
benefit in patients receiving treatment via pelvic floor muscle training, 
peripheral stimulation or vaginal support devices. The subjective 
improvements were of the range of 54-58% for all three treatment 
modalities compared to 21% in an untreated group25. However, the 
urodynamic parameters stayed the same which may suggest a placebo 
effect.  
Pelvic floor exercises have been shown to improve symptoms 
stress urinary incontinence of and have also been recommended for 
prevention of pelvic organ prolapse in nulliparous women prior to 
pregnancy. Moderate weight loss has been shown to decrease stress 
urinary incontinence symptoms.  
The studies have shown that women with stress urinary 
incontinence had lower resting urethral pressures when compared to 
continent women26. Therefore, pharmacological methods to increase 
urethral pressure seem logical. Urethral tone is maintained by the release 
of noradrenaline on to the alpha adreno-receptors. Many different alpha 
adreno-receptor agonists have been used to treat stress urinary 
incontinence. The most widely used were ephedrine and norephedrine. 
Alhasso et al. reviewed the evidence for alpha adreno-receptor agonists 
and found limited evidence to recommend their routine use27. Beta 
adreno-receptor antagonists have been postulated to enhance alpha 
adrenoreceptor action by beta adrenoreceptor blockade. However, the 
clinical benefit of this has not been sufficiently reported.  
Duloxetine, a serotonin nonadrenaline reuptake inhibitor has been 
licensed for the medical management of women with stress urinary 
incontinence. It is understood to work on the urethral rhabdosphincter. 
Both noradrenaline and serotonin are thought to lead to enhanced 
contraction of the sphincter via a potentiating effect on glutamate. 
Women taking Duloxetine for eight weeks were found to have a 
significantly higher mean urethral pressure profile, maximal urethral 
closure pressure but not functional urethral length. A randomized 
control trial in 533 women found Duloxetine to significantly decrease 
incontinence episode frequency in 64% of women at a dose of 
80mg/day. At that dose 15% of women discontinued the drug due to non 
severe side effects most commonly nausea28. Further clinical trials have 
also led to this conclusion. Higher doses have been associated with 
psychiatric disorders which has limited its popularity.  
Oestrogens have a significant role in maintaining continence in 
women.  In addition to oestrogen receptors existing in the vagina, 
levator muscles, ligaments and fascia, oestrogen plays an important role 
in the maintenance of a positive urethral pressure. Exogenous oestrogens 
have been shown to reduce collagen concentration and decrease 
collagen cross linking in urogenital tissues17. 
As lack of collagen is thought to be a cause for pelvic floor 
disorders, many researchers have attempted to inject collagen para-
urethrally, to act as a urethral bulking agent. A Cochrane review found 
peri-urethral collagen injections for stress urinary incontinence to have a 
reasonable short term cure, but a multicentre randomised trial found a 
19% reduced success rate with collagen injection compared to surgery29.  
Other urethral bulking agents have been used ranging from 
autologous fat, carbon particles, calcium hydroxyapetite, ethylene vinyl 
calcohol copolymer, dextranomer and silicone based Macroplastique. 
The latter has been found to have the greatest efficacy over the others.  
 Macroplastique is a urethral bulking agent involving injection of 
cross-linked polydimethylsiloxane. It is a soft, flexible implant, which 
upon implantation is encapsulated in fibrin. The carrier gel is absorbed 
leaving the fibrous capsule, which is thought will not migrate. Recently 
Ghoniem et al. reported a multicentre single blinded randomized control 
trial comparing collagen injection to Macroplastique30. The cure rate at 1 
year was 36.9% of patients in the Macroplastique group compared to 
24.8% in the collagen group. The risk of urinary retention was 3.2 and 
6.6% and urethral erosion was 0.8 and 1.6 % respectively. Given the 
cure rates are less than that reported for surgery; many surgeons would 
not use bulking agents as first line. However, it may be considered for 
use as second line after failed surgery. Moreover, if used as a first line 
treatment, many note an adverse effect on consequent surgical 
intervention.  
Surgical treatment 
                  The aims of the corrective surgeries are compressing the 
outlet, repositioning or restoring the sphincteric unit to higher 
intraabdominal location, provide backboard and coaptation at rest.  
Anterior colporrhaphy with bladder neck plication 
Anterior colporraphy is inidicated in patients with cystocele, if 
there is associated stress urinary incontinence. The plication sutures 
provide support to and/or elevate the urethra and/or bladder neck. Many 
variations of the procedure exist. Meta-analysis has reported the success 
rate of this procedure to be in the region of 67.8-72%. The serious 
complications are seen is 1% and the detrusor overactivity is seen in 6%. 
At five years the continence rate was found to decline to just 37%, thus 
making this procedure unpopular31.  
Retropubic suspension procedures 
 In these procedures, bladder neck displacement and urethral 
hypermobility are corrected by resuspending endopelvic fascia to 
various fixed points in retropubic space. In Marshall-Marchetti-Krantz 
procedure, the sutures are placed in the endopelvic fascia along the 
urethra and then into the periosteum along the back of pubic symphisis. 
The cure rate was 88% and the improvement was seen in more than 91% 
of the patients, but the risk of osteitis pubis had been reported in three 
percent of the patients.  
 Burch Colposuspension is a longstanding effective treatment. The 
sutures are placed in the endopelvic fascia along the bladder edge down 
to bladder neck and fixed to the illiopectineal ligament of Cooper. This 
procedure is highly effective and appears to remain so with time. It is 
reported as having a continence rate of 83-87% at one year32. A 51% 
objective cure rate has been reported at two years by Ward and Hilton in 
a multicentre randomised trial. At five years the authors reported a 90% 
negative pad-test amongst women in the colposuspension arm of the 
trial33. Complications reported from this study showed a rate of 39.8% 
of pelvic organ prolapse after this procedure and reoperation rates for 
incontinence of 3.4%. 
 In Paravaginal repair, the endopelvic fascia is reattached to arcus 
tendineus bilaterally with precaution to avoid injuring obturator 
neurovascular bundle. Turner Warwick has introduced the vagino-
obturator shelf procedure which is intermediate between classic Burch 
& Paravaginal repair. The endopelvic fascia is sutured to fascia over 
obturator internus. 
Laparoscopic Colposuspension 
 Laparoscopic colposuspension is the most popular of the 
laparoscopic incontinence procedures. As in open colposuspension, 
sutures are inserted into the paravaginal tissues on either side of the 
bladder neck and then attached. The results are conflicting until longer 
studies are available no conclusions can be drawn. Various studies 
suggests that the results are surgeon-dependent  
Needle suspension procedure 
Needle suspension procedures use suspending sutures and patch 
materials to suspend the bladder neck, usually from bone anchors placed 
in the pubic bone or from the rectus fascia. These are seldom used due 
to poor success rates. Though these procedures had initial success rate, 
but on long term followup the risk of failure was greater than retropubic 
suspension procedures34.  
Pubovaginal slings 
 Pubovaginal slings have been used for many years. Price 
described the first rectus fascia sling in 1933. The sling is placed 
beneath the bladder neck and the amount of tension on the sling requires 
an individualized approach. A sling which is too tight may lead to 
urinary retention and conversely a sling that is too loose may lead to 
recurrence. Tissue may be obtained from many different sources such as 
autografts, allografts and xenografts.  
The success rates of pubovaginal slings vary according to the type 
of material used. The success reported with cadaveric fascia is mixed, 
ranging from 33 to 93%. The rectus fascia sling has a success rate of 
approximately 80% depending on the level of patient selection and 
follows up. The success rates with porcine dermis have been found to be 
54% at 36 months follow up. However, Abdel-Fattah et al. found no 
difference in improvements in cure, defined by improvements in quality 
of life, between porcine dermis and Tension free transvaginal tape35. 
Tension-free Transvaginal tape (TVT) 
Mid-urethral sling (MUS) procedures are currently the gold 
standard of the surgical treatment for stress urinary incontinence. They 
were the first incontinence procedures that were designed on a 
previously well-defined pathophysiological theory: the Integral Theory 
and the Hammock Hypothesis. Both theories have in common that a 
connective tissue band underneath the middle part of the urethra (located 
between the back part of the urethra and the anterior vaginal wall) 
supports the backside of the urethra during moments of sudden rise of 
the intra-abdominal pressure. Contraction of the horseshoeshaped 
urethral muscles that are located in the anterior wall of the urethra 
causes the urethra to be pushed against this connective tissue band and 
consequenltly, the urethra is closed. The Integral theory also emphasizes 
the importance of the support function of the pubo-urethral ligaments 
which connect the urethra to the backside of the pubic symphysis. 
Tension-free Vaginal Tape (TVT) was introduced by Ulmsten et 
al. in 1996. Trans Vaginal tape is a polypropylene tape that runs from 
underneath the middle part of the urethra behind the pubic bone and in 
front of the bladder to the lower abdominal wall36. Follow-up data after 
10-12 years show cure and improvement rates of respectively 77 and 
20%. 
Due to the blind passage through the retropubic space bladder 
perforations, vessel injury and even bowel injury have been described. 
Postoperative voiding difficulty and de novo urgency or urge 
incontinence are regarded the most important functional complications. 
Transobturator vaginal tape 
In order to address the complications of tension free transvaginal 
tape, other modifications were developed. In 2001 Delorme introduced 
the Transobturator tape procedure, a new method of inserting a 
polypropylene tape with a high success rate for curing stress urinary 
incontinence. The tape runs from underneath the urethra through the left 
and right obturator membrane onwards to the upper inner side of the 
thigh36. 
There are two basic techniques for performing transobturator 
tape: “Inside - Out” (TVT-O) which was described by de Leval and 
“Outside - In” (TOT) described by Delorme. Both these procedures 
differ not only on the direction of needle and also differ on the type of 
surgical equipments like introducer. After the introduction of the 
“Outside-In” technique by Delorme in 2001 several other similar 
procedures were developed. Among them is Monarc, which, like 
transvaginal tape, is a monofilament macroporous polypropylene mesh. 
It has shown similar and equally good short-term to medium-term 
success rates as TVT-O. 
The advantage of the obturator approaches is that blind passage of 
the introducer in the retropubic space is avoided. Therefore, 
theoretically, the risk of bladder or bowel perforation is minimized. A 
metanalysis procedure comparing transobturator approaches with 
retropubic colposuspension has shown objective cure and improvement 
was comparable in both the techniques32. The incidence of postoperative 
complications like lower urinary tract injuries, visceral injury were less 
with transobturator approach except for the groin pain which was more 
than 15% in the immediate postoperative period. Groin pain was 
transient and the patients were pain free during the follow up.  
 
Complications  
Complications of stress urinary incontinence surgery may be divided 
into intraoperative and postoperative. Intraoperative complications 
involve injury to organs, vessels and nerves. The injury may occur to:  
 Urethra: This is a rarely reported complication. It may occur 
during transvaginal dissection or trocar placement. Failure to 
recognise this leads to the risk of urethrovaginal fistula 
development and sling erosion/infection.  
 Bladder: Bladder injury varies with the surgical approach. Albo et 
al. reported more injuries with colposuspension compared to sling 
procedures. At meta-analysis the risk of bladder perforation is less 
with transobturator tape compared to transvaginal tape37. 
 Ureter: Ureteric injury is very uncommon, but the ureter may be 
kinked during a Burch colposuspension. The position of the 
midurethral sling makes it extremely unlikely for the ureters to be 
encountered.  
 Blood vessels: Multiple blood vessels traverse the deep pelvis; 
these are at risk in the obturator fossa and pelvic side walls. The 
iliac vessels and vascular pedicle of the bladder are at risk 
especially during blind passage of trocars or needles.  
 Bowel: Bowel injury is very rare, only being reported in case 
reports. It can happen during dissection in the retropubic area for 
colposuspension or pubovaginal sling or during trocar passage for 
a midurethral sling.  
 Nerve injury: Injuries to nerves may occur during harvest of 
rectus fascia or during trocar movement in the pelvis.  
Postoperative complications 
 Voiding dysfunction and urinary retention- symptoms range from 
difficulty voiding to complete retention and/ or urge incontinence. 
Post-op voiding difficulties lasting more than four weeks occur in 
4-8% of burch colposuspension procedures and 3-11% of sling 
procedures38. Permanent retention is rare and can occur in five 
percent of patients. Similarly five percent of women who 
underwent midurethral sling procedures may require a surgical 
treatment during the followup period.  
 Infection- multiple case reports of pelvic abscesses have been 
reported post stress urinary incontinence  surgery  
 Vaginal extrusion and urinary tract erosion- extrusion implies the 
presence of sling in the vaginal cavity and erosion refers to the 
appearance of sling in the urinary tract. Extrusion rates have been 
found to be higher with multifilament slings as opposed to 
monofilament. The risk of extrusion with monofilament slings is 
less than 5%. The risk of erosion is reported to be less than 1%.  
 
Outcome measures of stress urinary incontinence surgery  
 Comparable scientific assessment is necessary in the evaluation of 
stress urinary incontinence surgery, to allow comparison between 
procedures and guide best practice. The commonly used methods of 
both objective and subjective assessment are discussed below. Any 
outcome measure must be reliable, valid, interpretable and responsive to 
change.  
Objective measures:  
 Urodynamics- has been found not to show stress urinary 
incontinence in 15% of women with primary stress urinary 
incontinence. Post operatively, Azam et al. demonstrated almost 
40% of women, who complained of persisting stress urinary 
incontinence, did not show leakage on urodynamics39. Although 
urodynamics is the gold standard for the objective assessment of 
this condition, its reliability is not proven.  
 Cough stress test- may be used to assess cure, but may not be 
used to assess improvement41. Prior to commencing the test, 
bladder volume, number and force of coughs should be 
standardized. However, currently no standards exist.  
 Pad tests- have been used to objectively define cure, using a cut 
off depending on the test duration and standardization. The 1 
hour, 24 hours and 72 hours pad test have been validated40.  
 Bladder diaries- have been shown to be a reliable measure but 
rely on the duration of the test and are currently not standardized.  
Subjective measures:  
 ICIQ questionnaire- is a modular questionnaire which has been 
validated, shown to be reliable and is used in many research 
studies. The ICIQ modular questionnaire is an amalgamation of 
other existing questionnaires. The modules range from core 
symptom modules, quality of life modules and optional modules.  
 Satisfaction outcomes- ascertain from patients their satisfaction 
from a certain intervention. This relies heavily on patient goals 
and expectations and Norton has shown a reduction of leaks by 
50% does not entail a 50% improvement in satisfaction42.  
 
 
 
 
 
  
 
 
 
MATERIALS & 
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MATERIAL AND METHODS 
Study Design: Prospective study 
Duration: September 2011 to May 2013 
Setting: Govt. Stanley Medical College and Hospital, Chennai. 
Inclusion Criteria: 
1) Patients in the age group between twenty five to eighty five years. 
2) Clinical as well as urodynamic diagnosis of stress urinary 
incontinence. 
3) Positive pad test, stress-test. 
Exclusion Criteria: 
1) Detrusor overactivity or impaired bladder contractility. 
2) Post void residual urine 100 ml or greater. 
3) Pregnancy.  
4) Neurological pathology. 
5) Active urinary or vaginal infection. 
 
 
 
Methodology: 
A total of 25 patients with stress urinary incontinence in 
Government Stanley Hospital during the period November 2010 to 
January 2013 were asked to participate in this prospective study.  All the 
women underwent a standardized preoperative evaluation including 
detailed incontinence history regarding duration and severity of stress 
urinary incontinence. All the patients underwent pelvic examination, a 
stress-test in upright position and a short term pad test. 
 Urodynamic tests such as pressure flow study was performed in 
all patients for diagnosis of stress urinary incontinence and 
discrimination from urge incontinence. Urodynamic evaluation was 
done using Laborie and Medical Measurement System urodynamic 
device. A sterile 8 French dual channel cystometry catheter was placed 
into the urethra and a rectal catheter with 5 ml balloon was placed into 
the rectum. The urinary bladder was filled with saline solution at the rate 
of 50 ml/min and the patient was asked to cough after each 100 ml 
filling. Urinary incontinence occurring in this time was detected and the 
diagnosis of stress incontinence was made. Abdominal leak point 
pressure was measured in all patients and recorded. 
  All patients were administered parentral first generation 
cephalosporin preoperatively for antibacterial prophylaxis. The inside 
out transobturator procedure was performed as described by Leval. All 
patients were administered regional (spinal) anesthesia. Cystoscopy was 
performed to evaluate the bladder and urethra after the procedure. The 
duration of the procedure, cystoscopy and any additional operations, if 
performed, were recorded. All patients were monitored with the Foley 
catheter for bladder drainage for 48 hours. Postoperative follow-up was 
done at six weeks, three and six months. The objective cure was 
evaluated with a negative stress-test and 24-hour pad test.  The 
subjective cure was also evaluated based on satisfaction of the patient 
with the procedure. 
 The influence of inside out transobturator tape on quality of life of 
the patients was evaluated with the Incontinence Quality of Life  
(I-QOL) pre- and postoperatively.  
 
 INCISION OF VAGINAL WALL AND PARAURETHRAL SPACE 
DISSECTION WITH FINE SCISSORS 
TVT-O DEVICE: HELICAL PASSER WITH ATRAUMATIC 
WINGED GUIDE 
 
HELCIAL PASSER APPEAR AT THE PREVIOUSLY DETERMINED 
SKIN EXIT POINT 
WINGED INTRODUCER PUSHED ALONG DISSECTED SPACE 
UNTIL IT PERFORATED THE OBTURATOR MEMBRANE 
  
 
 
 
 
RESULTS 
 
 
 
 
 RESULTS 
AGE DISTRIBUTION 
Age in years Number of patients Percentage of Total 
21-30 1 4% 
30-40 11 44% 
41-50 8 32% 
>50 5 20% 
 
 
A total of 25 patients with stress urinary incontinence were 
admitted in the present study. The average age of the patient was  
42.08 ± 8.49 years. 
 PARITY 
Parity Number of patients 
1 1 
2 13 
>2 11 
 
 
The mean parity of the patients with stress urinary incontinence 
was 2.52 ± 0.77 (Mean ±SD). The data collected indicated that the 
women with 2 children had more Stress Urinary Incontinence 
 
 
 
 MENOPAUSAL STATUS 
Menopausal status Number of patients 
Percentage  
of  total 
Pre menopausal 13 52% 
Post menopausal 12 48% 
 
 
Around thirteen patients (52%) with stress urinary incontinence 
were premenopausal and 12 patients out of twenty five were 
postmenopausal.  
 
 
 
 
 MODE OF DELIVERY  
 Mode of deliveryNumber of patients 
Vaginal delivery 23 
Caesarean section 2 
 
 
23 patients in this study underwent vaginal delivery and 2 patients 
had undergone caesarean section. Women who have had vaginal 
deliveries were found to have a higher association with stress urinary 
incontinence. 
 
 
 
 PREVIOUS PELVIC SURGERIES 
Prior pelvic surgery Number of patients 
Abdominal hysterectomy 3 
Vaginal hysterectomy 2 
Caesarean section 2 
 
 
Seven patients with stress urinary incontinence had undergone 
previous pelvic procedures; three patients had previous history of 
abdominal hysterectomy, two patients had undergone a vaginal 
hysterectomy and two patients had undergone a caesarean section. 
 
 
 
 PREOP CLINICAL PARAMETERS 
Preop clinical parameters Mean ± S.D 
Symptom duration (years) 4.56 ± 1.75 
SUI grade (range 1-3) 2.24 ±0.52 
  
 
 
The average symptom duration noted in patients with stress 
incontinence was 4.56 years, ranging from one year to eight years. 
Average stress urinary incontinence grade was 2.24 (range 1-3). 
 
 
 
 
 PREOPERATIVE URODYNAMIC PARATMETERS 
Preoperative urodynamic parameters Mean ± S.D 
Peak flow rate (ml/sec) 29.36 ± 2.65 
Postvoid residual urine (ml) 21.2 ± 12.01 
Abdominal leak point pressure (cmH2O) 79.28 ± 6.75 
 
 
The peak flow rate of the patients with stress urinary incontinence 
observed was 29.36 ml/second, and the post void residual urine 
measured by ultrasound abdomen was 21.2 ml. The abdominal or 
valsalva leak point pressure measured by pressure flow study was 79.28 
cmH2O. 
 
 
 OPERATIVE PARAMETERS 
Procedural parameters Mean ±S.D Range 
Operative time 36 ± 6.12 25 – 45 min 
Blood loss 40 ± 9.12 10 – 40 ml 
Hospital stay 3.08 2 – 4 days 
 
 
The mean operating time of inside out transobturator approach 
was 36 minutes (range 25 to 45 minutes). The average blood loss during 
this procedure was 40 ml. The average duration of stay in the hospital 
during this study was only 3 days. All the patients underwent 
cystoscopy to detect any intraoperative complications - urethral or 
bladder injury. 
 
 POSTOPERATIVE COMPLICATIONS 
Complications Number of patients (%) 
Groin pain 3 (12%) 
Retention 1 (4%) 
Urgerncy 1 (4%) 
Hematoma 1 (4%) 
 
 
Following removal of the catheter post procedure one patient 
developed retention of urine requiring recatheterisation, but she had no 
voiding dysfunction after removal of catheter after one week. Groin pain 
was noted in 3 women during postop period. One patient developed 
wound hematoma and one patient had urgency and she was treated with 
antimuscarinics and on regular follow-up. Other serious postoperative 
complications like vaginal / urethral erosion, urinary tract infection, 
fistula, etc was not noted in the present study. 
 
SURGICAL OUTCOMES  
Surgical outcome Number of patients (%) 
Cure 23 (92%) 
Improved 2 (8%) 
Failure - 
 
 
Surgical outcome following inside out transobturator repair was 
assessed and categorized as cured, improved and failure of the 
procedure. It was based on list of questionnaires, stress test and pad 
tests. The results of this study are as follows – cured 92% , improved 
8%, and there was no failure in this approach 
 
 
 SUBJECTIVE OUTCOME 
Subjective satisfaction Number of patients (%) 
Very satisfied 21 (84%) 
Satisfied 4 (16%) 
Not satisfied - 
 
 
The rate of satisfaction of the inside out transobturator approach 
was assessed during followup. 21 patients (84%) were very much 
satisfied with the procedure and 4 patients (16%) were satisfied with the 
procedure. 
 
 
FOLLOWUP 
FOLLOWUP PREOP POSTOP 
Peak flow rate (ml/s) 29.36 ± 2.65 26.65 ± 2.12 
Post void residual urine (ml) 21.2 ± 12.01 15.23 ± 6.01 
 
 
At 6 months follow-up, postoperative assessment of peak flow 
rate and the residual urine was done. The mean peak flow rate during the 
follow up was 26.65 ± 2.12, the mean post void residual urine during the 
follow-up was 15.23 ±  6.01. 
 
 
 
 
I-QOL (QUALITY OF LIFE)  
I-QOL SCORES 
Preop  
(Mean + SD) 
Postop  
(Mean + SD) 
Total 51.52  ±  5.49 96.84  ±  1.43 
Avoidance + limiting behaviour 49.2  ±  5.52 97  ±  1.58 
Psychosocial impacts 50.36  ±   6.76 97.04  ±  1.54 
Social embarassment 48.16  ±  5.19 97.68  ±  1.97 
 
 
All the patients in this study were evaluated using International 
Quality of Life Questionnaires and the scores were converted to 0 to 100 
scale. Scoring was obtained both preoperatively and postoperatively 
during the follow-up. 
  
 
 
 
 
DISCUSSION 
DISCUSSION 
The tension free vaginal tape procedure described by Ulmsten has 
revolutionized the treatment of female stress urinary incontinence.  
Ulmsten’s theory is based on the concept that the urethral continence 
mechanism is controlled by the interplay of three anatomical structures 
and their associated function: the tension of the pubourethral ligaments, 
the muscular activity of the pubococcygeus and levator ani, and the 
condition of the suburethral vaginal hammock.  
While these tapes have proved their long term efficacy44, their 
insertion via an ascending or descending retropubic approach has been 
associated with number of intraoperative complications including 
bladder perforations, urethral injuries, retropubic hematoma formation, 
and rarely, complications with significant consequences such as injury 
to bowel, major blood vessels and nerves40.  
The transobturator approach was first described by DeLorme in 
2001 for placement of midurethral vaginal tape with the aim of sparing 
pelvic space. In this outside in approach the needle is passed through a 
skin incision in the thigh fold, through the inferior-medial aspect of the 
obturator foramen, the anterior recess of the ishiorectal fossa under the 
levator muscles, and through the pubocervical fibromuscular tissue to 
exit a suburethral incision. The tape was then withdrawn through the 
same path. The same procedure was performed on the opposite side to 
form the midurethral sling45.  
Initial data have demonstrated similar cure rates when compared 
to traditional retropubic placement with a lower incidence of bladder 
injury. The results from various clinical studies supported by cadaver 
dissections have demonstrated the injuries to the bladder, urethra, and 
vagina. Noteworthy, bladder perforations have been observed despite 
the recommended use of a large lateral para-urethral dissection to allow 
the introduction of a finger, employed to guide the tunneler. Therefore, 
systematic intra-operative cystoscopy may be needed while performing 
this procedure, in particular for avoiding unrecognized bladder or 
urethral perforations.  
In an attempt to further improve upon the intraoperative safety 
profile of an obturator approach, de Leval had described an inside out 
transobtuator technique of tape placement with a helical passer that 
begins at the vaginal incision, follows the same path and exists the skin 
2 cm lateral to the thigh fold thus earning it the “inside-out” designation.  
The surgical device consists of stainless helical passer, 
polyethylene plastic tubes, stainless tube introducer and a polypropylene 
mesh. In order to determine the anatomical trajectory of the inside out 
transobturator tape and the neighbouring structures, de Leval et al. have 
performed cadaver dissections.  These studies demonstrated that the tape 
had followed the following consistent path: it penetrated from the 
suburethral space into the anterior recess of the ischio-rectal fossa, 
limited medially and cranially by the levator ani muscle, caudally by the 
deep transverse muscle, and laterally by the internal obturator muscle. 
The tape then perforated the obturator membrane and muscles and 
exited at the skin level after passing through the adductor muscles and 
sub-cutaneous tissues45.  
The transobturator tape was at a significant distance away form 
pudendal nerve, the obturator nerve and vessels, and the femoral vessels. 
The obturator vascular structures were also carefully dissected. 
Dissections consistently showed that the anterior branch of the obturator 
artery lied on the external rim of the ischio-pubic ramus, and was thus 
protected by this bony structure from being injured by the insertion of 
the tape47.  
Like the outside in approach (TOT), the inside out (TVT-O) tape 
passes from the midurethral level to obturator and thigh regions, and 
thus avoiding the pelvic cavity. The urethra and vaginal walls are under 
direct view47. The TVT-O tape is inserted into a rigorously perineal 
space, without traversing the levator ani muscle or its tendinous arch, 
making cystoscopy unnecessary, when properly performing the surgical 
procedure.  
Spinosa and Dubuis (2005)48 followed up 117 patients who 
underwent inside out transobturator approach for 16.3 months, and the 
complete and partial subjective cure rates were found as 92.3% (n:108) 
and 4.2% (n:5), respectively. Overall, four patients stated that their 
condition did not change. In another study that 120 patients were 
followed up for one year, 80% patients reported that they were 
completely dry and 12% reported that they had recovered almost totally. 
The initial reports of this inside out approach are encouraging 
suggesting a similar efficacy with no reported adverse events. Long term 
data demonstrating sustained efficacy of the transobturator approach has 
been demonstrated by various clinical studies. 
 Stress Urinary Incontinence was more commonly seen in younger 
women in this our study that is comparable to prevalence seen in other 
clinical studies. The higher level of physical activity seen in younger 
women than that of older women could be the reason. The average age 
of the patients was 42.08 years, whereas in a study conducted by Swift 
and Ostergard, average age was 59.8 years49. 
 The mean parity, the number of children women had in our study 
was 2.52. The data collected indicated that the women with 2 children 
had more stress urinary incontinence, but the fact that almost half of the 
study population had only two children must be taken into 
consideration50. 
 In our study stress urinary incontinence was equal amongst 
premenopausal women (52%) and postmenopausal women (48%) 
similar to the results by Fultz et al51.  
Patients with vaginal delivery were found to have a higher 
association with stress urinary incontinence. As shown in present work, 
women who had vaginal deliveries more likely to develop stress urinary 
incontinence than patients who had caesarean section. In a prospective 
study by in 344 nulliparous women it has shown that vaginal delivery 
has 18 times increased risk of urinary incontinence in a year when 
compared to caesarean delivery50.  
 In this study 12% of patients had undergone abdominal 
hysterectomy and 8%   vaginal hysterectomy compared to 25.4% and 
9.6% respectively quoted by Bidmead et al52. 
 There is latency from onset of symptoms to help-seeking in 
women with stress urinary incontinence. From the data gathered, it 
appears that most people tended to seek treatment between one and five 
years from the onset of their symptoms. There could be several reasons 
as to why people wait and as to why some people wait longer than 
others, ranging from personal to economical to logistical issues50. 
  The present study shows that  of women with stress incontinence 
had 4%, 68%, 28% grade1,2,and 3 respectively while Teleman et al 
reported that only 20% had occasional episodes of incontinence and 
80% were incontinent all the time53. 
 The mean procedural time was 36 minutes including an additional 
cystoscopy. This was similar to mean operative time of transvaginal tape 
as reported by Abouassaly et al54. The average intraoperative blood loss 
in the present study was 36 ml, and no patient had blood loss greater 
than 100 ml. Various studies50 have shown the average blood loss during 
transvaginal tape procedure was significant and around 2% to 5% of 
patients had blood loss greater than 100 ml. 
 De Leval in his study of around 100 patients with stress urinary 
continence has demonstrated the absence of bladder or urethral injuries 
and no vascular (hematoma or bleeding) or neurologic complications55. 
The present study has demonstrated that no patient had signs and 
symptoms of vaginal, urethral, or bladder injury or erosions; or 
persistent pain during the 6 months follow-up period. The rate of  
urinary retention and hematoma is similar to the prospective study by  
Waltregny et al. 
 The postoperative groin pain was seen in 4 (16%) patients in this 
study. The cause for the postoperative pain with this procedure was due 
to a less predictable, more lateral passage of the needle and thus a closer 
exit to the obturator nerve in the groin. Most of the patients settled with 
oral analgesics and they were pain free during the follow-up at 3 
months57. 
 Denovo urge symptoms are commonly seen in patients 
undergoing surgical management for stress urinary incontinence. 
DeNeval58 in his study has demonstrated that urge symptoms 
disappeared or decreased in 72.8% and 6%, respectively, among the 33 
patients who suffered from this condition pre-operatively. No change in 
urge symptoms was noted in five patients (15.2%) and six out of 96 
patients developed de novo urge incontinence (6.25%). The incidence of 
de novo urgency is more common with transvaginal tape when 
compared to transobturator tape because of proximity of the tape to the 
bladder which can penetrate and irritate the bladder. In transobturator 
approach the tape is subfascial and avoids the retropubic space. In the 
present study postoperative urgency was seen in one patient. 
The present study showed an objective cure rate of 92% and there 
was no failure of the procedure. On subjective assessment 84% of 
patients were very much satisfied with the procedure and 16% were 
satisfied with the procedure during the follow-up. De Neval58 in his 
study of inside out transobturator approach among 108 patients with 
more than 6 months follow-up, 98 were cured (90.7%), 4 improved 
(3.7%) and 6 failed (5.6%). 
 The results from inside out approach showed a significant 
improvement between preoperative and postoperative assessment scores 
for health related quality of life (I-QOL). All the patients who had 
undergone this procedure reported improvement in the total score as 
well as the subscale scores – avoidance and limiting behaviour, 
psychosocial impact and social embarrassment (Incontinence – Quality 
of Life score). This result was comparable to other midurethral tapes 
which also have shown improvement in quality of life. 
 Waltregny et al59 (2006) found complete cure rate of 91% after 
TVT-O procedure on one-year follow up. A significant improvement 
was also detected in the quality of life and severity of incontinence in 
most patients. In another study follow up of four months, the objective 
and subjective cure rates were found to be 92 and 97%, respectively. An 
improvement was observed in the quality of life of 96% patients 
(Cindolo et al., 2004)60. In an additional study including 94 patients with 
a mean of 12.8 months of follow up, the cure rate was found to be 95% 
(Mellier et al., 2004)61.  
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
CONCLUSION 
CONCLUSION 
The inside out transobturator approach (TVT-O) is an effective 
and safe technique for the treatment of female stress urinary 
incontinence. The anatomical and functional mechanism of continence 
is restored with this minimally invasive approach. The position of the 
transobturator tape is similar to that of the natural hammock supporting 
the urethra, respects the orientation of muscle fibres better than the 
tension free transvaginal tape operation, and the dissection is less 
extensive, making tape migration less likely to occur. The para-urethral 
subvaginal dissection is less extensive with the inside-out route and the 
learning curve of this approach appears to be quicker. 
There are several proven advantages concerning the feasibility of 
the inside out transobturator technique compared to the transvaginal tape 
procedure: the short duration of the operation; the low risk of urethral 
and bladder lesion, making cystoscopy redundant; the absence of risk of 
bowel lesion; the low risk of haemorrhage. Initial and long term results 
appear to suggest a cure rate similar to that of the transvaginal tape 
procedure and outside in transobturator approach with decreased 
incidence of complications.  
 On conclusion, the inside-out transobturator technique is simple, 
quick, and safe. It allows the accurate passage of the tape with minimal 
dissection, protection of the urethra and avoiding the pelvis. There have 
been no reported urethra or bladder injuries, and no bowel or 
neurological complications. Post-operative continence rates are similar 
to the transvaginal tape procedure on short-term follow-up. In the future 
more randomized studies are necessary comparing the various 
midurethral slings and to further establish efficacy and safety of inside 
out transobturator vaginal tape. 
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PROFORMA 
PROFORMA 
Name:                   
Age/ Sex:  
Hospital No: 
Date of Admission: 
Date of Surgery: 
Date of Discharge: 
Presenting History: 
- Incontinence – aggravated by stress 
- Urgency 
- frequency of micturition 
- pain – suprabubic or dysuria 
- haematuria 
- altered bowel habits 
- chronic cough 
Past History: 
- recurrent urinary tract infections 
- drug intake 
- previous pelvic surgery 
- known DM/HT/PTB 
Obstetric History: 
- Parity 
- Mode of Delivery 
- Forceps or breech delivery 
Clinical Examination: 
 General Examination: 
 Abdominal Examination: 
 PV: 
 PR: 
 IQOL questionnaire: 
INVESTIGATIONS: 
Basic Investigations: 
- Urine routine 
- Urine C/S 
- Renal Parameters 
- Ultrasound KUB: post void residual urine assessment 
Bladder diary: 
Cystoscopy: 
Urodynamic Evaluation: 
PROCEDURE: 
- Date of surgery: 
- Anaesthesia:  
- Findings:  
- Operative time: 
- Blood loss: 
Post op Period: 
- Retention of urine 
- Voiding dysfunction  
- Urgency 
- Groin  pain 
- Wound hematoma 
- Tape erosion/extrusion 
- Urinary tract infection 
 
Follow-up: 
 
 
MASTER CHART 
S
l
.
N
o
 
N
a
m
e
 
A
g
e
 
P
a
r
i
t
y
 
M
e
n
o
p
a
u
s
e
 
P
e
l
v
i
c
 
S
u
r
g
e
r
y
 
M
o
d
e
 
o
f
 
D
e
l
i
v
e
r
y
 
I
Q
O
L
-
T
 
I
Q
O
L
-
A
 
I
Q
O
L
-
P
 
I
Q
O
L
-
S
 
S
y
m
p
t
o
m
 
D
u
r
a
t
i
o
n
 
G
r
a
d
e
 
P
e
a
k
 
F
l
o
w
 
R
a
t
e
 
P
V
R
 
A
L
P
P
 
O
p
e
r
a
t
i
v
e
 
t
i
m
e
 
B
l
o
o
d
 
l
o
s
s
 
H
o
s
p
i
t
a
l
 
s
t
a
y
 
P
a
i
n
 
R
e
t
e
n
t
i
o
n
 
H
e
m
a
t
o
m
a
 
U
r
g
e
n
c
y
 
P
o
s
t
 
v
o
i
d
 
r
e
s
i
d
u
e
 
P
e
a
k
 
f
l
o
w
 
r
a
t
e
 
C
u
r
e
d
 
I
m
p
r
o
v
e
d
 
F
a
i
l
e
d
 
V
e
r
y
 
S
a
t
i
s
f
i
e
d
 
S
a
t
i
s
f
i
e
d
 
N
o
t
 
S
a
t
i
s
f
i
e
d
 
I
Q
O
L
-
T
 
I
Q
O
L
-
A
 
I
Q
O
L
-
P
 
I
Q
O
L
-
S
 
1 Kothanayaki 36 2  - VD 68 65 64 60 3 2 32 20 82 40 50 3     nil 28  x   x  96 95 96 96 
2 Krishnaveni 45 3 x - VD 52 50 55 52 6 2 28 30 74 35 30 2     20 24 x   x   98 98 98 100 
3 Jayanthi 59 4 x AH VD 49 45 49 40 3 2 29 nil 86 45 50 3 x    10 26 x   x   100 100 100 100 
4 Noorjahan 59 3 x - VD 46 43 40 48 5 3 31 10 88 30 40 4     nil 28 x    x   98 98 98 100 
5 Thilaka 54 2 x - VD 50 48 53 48 6 2 26 nil 72 25 30 3     20 24 x   x   97 98 96 100 
6 Karpagam 45 2  - VD 46 52 49 52 4 3 28 30 78 35 40 3     20 24 x   x   96 95 96 96 
7 Alamelu 32 2  - VD 55 58 66 52 3 2 34 40 82 40 30 4     10 28 x   x   98 98 98 100 
8 Sivakami 36 2  AH VD 52 45 51 44 4 2 34 20 78 50 60 4 x    10 26 x   x   97 98 98 96 
9 Krishnaveni 32 2  LSCS CS 47 45 42 44 4 2 31 10 70 30 40 3     10 30  x   x  94 95 94 96 
10 Maliga 52 3 x - VD 52 48 51 44 7 2 32 20 64 35 30 3     nil 25 x   x   98 98 98 100 
11 Radha 35 2  - VD 51 48 46 48 2 3 28 30 86 40 40 3     10 26 x   x   96 95 96 96 
12 Thenmozhi 38 3  VH VD 53 48 49 48 3 2 26 20 80 35 50 2     20 29 x   x   97 98 98 96 
13 Rama 36 2  - VD 64 60 62 54 6 2 28 20 92 30 40 3     20 26 x   x   98 98 98 100 
14 Chitra 40 2 
 
- VD 45 45 40 40 3 3 31 30 80 25 30 3 
    
10 28 x 
  
x 
  98 98 98 100 
15 Sheela 44 2 x LSCS CS 52 50 55 52 8 2 24 nil 84 40 50 4   x  20 26 x   x   97 98 98 96 
16 Vedhanayaki 38 3  - VD 53 50 53 48 3 3 32 30 78 35 50 3     nil 25 x   x   96 95 96 96 
17 Kumari 41 1  - VD 54 50 48 54 4 2 26 30 84 45 40 3     30 24 x   x   96 95 96 98 
18 Sakunthala 46 4 x VH VD 48 45 47 40 7 3 29 20 76 35 50 3 x   x 20 32 x   x   98 98 98 100 
19 Chandra 42 3 x - VD 50 48 53 48 6 2 28 30 82 40 40 3     20 28 x   x   97 98 98 96 
20 Esther 28 2  - VD 46 53 49 52 3 1 31 20 86 30 30 3  x   10 29 x   x x  94 95 94 96 
21 
Ayesha 
begum 36 4 x - VD 44 43 40 40 6 3 26 nil 76 40 50 3     20 24 x   x   96 95 96 96 
22 Muniammal 49 2 x AH VD 57 55 52 52 4 2 32 20 84 35 30 3     10 28 x   x   97 98 98 96 
23 Sundari 46 3 x - VD 52 45 51 44 1 2 28 30 80 30 40 3 x    nil 26 x   x   97 98 98 96 
24 Chellammal 51 3 x - VD 49 43 45 52 8 2 31 40 66 40 30 3     10 24  x   x  94 95 94 96 
25 Ramani 32 2    VD 53 48 49 48 5 2 29 30 74 35 30 3     10 28 x   x   98 98 98 100 
IQOL-T : incontinence quality of life score total 
IQOL-
A Avoidance and limiting behaviour 
IQOL-
P 
Psychosocial 
impact 
IQOL-
S 
Social 
embarrassment  PVR Post void residual urine ALPP Abdominal Leak Point Pressure 
